Two Recession-Resistant Dividend Stocks to Buy Now
In uncertain times, one reliable approach is to target recession-resistant dividend stocks. This article shines a lig...
Choosing between a stock index and an index fund depends on costs, flexibility, and your investment objectives. This article compares the options clearly.
25,679 articlesIn uncertain times, one reliable approach is to target recession-resistant dividend stocks. This article shines a lig...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
July has brought headlines that test investors' nerves. This piece breaks down what drove stock moves today, what Luc...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
Investors are watching novavax (nvax) 2025 earnings closely as the company pivots its vaccine portfolio. This article...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
The broadcom sell-off: this huge moment is more than a single stock move. It underscores how AI optimism meets market...
Cathie Wood goes bargain as Ark trims some bets and adds to three promising names. This piece breaks down the three s...
A notable stake by Starboard Value in Fluor hints at renewed confidence in the industrial cycle. This article explain...
Kinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...